Literature DB >> 20921431

Estrogen metabolomics: a physiologist's perspective.

Virginia M Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20921431      PMCID： PMC3018158          DOI： 10.1161/HYPERTENSIONAHA.110.154385

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  9 in total

1.  Therapeutic efficacy of 2-methoxyestradiol microcrystals encapsulated within polyelectrolyte multilayers.

Authors:  Su He Wang; Xiangyang Shi; Xisui Chen; James R Baker
Journal:  Macromol Biosci       Date:  2009-05-13       Impact factor: 4.979

2.  KEEPS: The Kronos Early Estrogen Prevention Study.

Authors:  S M Harman; E A Brinton; M Cedars; R Lobo; J E Manson; G R Merriam; V M Miller; F Naftolin; N Santoro
Journal:  Climacteric       Date:  2005-03       Impact factor: 3.005

Review 3.  Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  Arch Intern Med       Date:  2010-07-26

Review 4.  Functional role of estrogen metabolism in target cells: review and perspectives.

Authors:  B T Zhu; A H Conney
Journal:  Carcinogenesis       Date:  1998-01       Impact factor: 4.944

5.  A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer.

Authors:  Christopher Sweeney; Glenn Liu; Constantin Yiannoutsos; Jill Kolesar; Dorothea Horvath; Mary Jane Staab; Karen Fife; Victoria Armstrong; Anthony Treston; Carolyn Sidor; George Wilding
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

6.  2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats.

Authors:  Xinchen Zhang; Youhong Jia; Edwin K Jackson; Stevan P Tofovic
Journal:  J Cardiovasc Pharmacol       Date:  2007-01       Impact factor: 3.105

7.  DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy.

Authors:  Clemens B Tempfer; Eva-Katrin Riener; Lukas A Hefler; Johannes C Huber; Axel Muendlein
Journal:  Fertil Steril       Date:  2004-07       Impact factor: 7.329

8.  The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice.

Authors:  Johan Bourghardt; Göran Bergström; Alexandra Krettek; Sara Sjöberg; Jan Borén; Asa Tivesten
Journal:  Endocrinology       Date:  2007-04-19       Impact factor: 4.736

Review 9.  New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.

Authors:  Susan L Mooberry
Journal:  Curr Opin Oncol       Date:  2003-11       Impact factor: 3.645
  9 in total
  6 in total

1.  Sex Steroids and Incident Cardiovascular Disease in Post-Menopausal Women: New Perspective on an Old Controversy.

Authors:  Virginia M Miller; Rekha Mankad
Journal:  J Am Coll Cardiol       Date:  2018-06-05       Impact factor: 24.094

2.  Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease.

Authors:  Virginia M Miller
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

3.  Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS.

Authors:  L Raz; L V Hunter; N M Dowling; W Wharton; C E Gleason; M Jayachandran; L Anderson; S Asthana; V M Miller
Journal:  Climacteric       Date:  2015-12-10       Impact factor: 3.005

4.  Involvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cells.

Authors:  Qi Zhang; Yan Ma; Yue-Fang Cheng; Wen-Jie Li; Zhenzhong Zhang; Shao-Yu Chen
Journal:  Cancer Lett       Date:  2011-09-17       Impact factor: 8.679

5.  Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists.

Authors:  Virginia M Miller; Jay R Kaplan; Nicholas J Schork; Pamela Ouyang; Sarah L Berga; Nanette K Wenger; Leslee J Shaw; R Clinton Webb; Monica Mallampalli; Meir Steiner; Doris A Taylor; C Noel Bairey Merz; Jane F Reckelhoff
Journal:  Biol Sex Differ       Date:  2011-12-12       Impact factor: 5.027

Review 6.  Oncometabolites as biomarkers in thyroid cancer: a systematic review.

Authors:  Fatemeh Khatami; Moloud Payab; Masoumeh Sarvari; Kambiz Gilany; Bagher Larijani; Babak Arjmand; Seyed Mohammad Tavangar
Journal:  Cancer Manag Res       Date:  2019-02-25       Impact factor: 3.989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.